Pulmonary Fibrosis
Conditions
Brief summary
Pulmonary fibrosis (PF) is a chronic lung condition in which scar tissue gradually forms, impairing oxygen transfer and causing breathlessness. Individuals with PF frequently experience anxiety and depression, yet supportive care remains underdeveloped, and few evidence-based psychological interventions exist for this population, representing a critical gap in care. This feasibility randomised controlled trial (RCT) evaluated the Compassionate Mindful Resilience (CMR) programme, a 4-week online, nurse-led mindfulness-based intervention designed to improve psychological outcomes in people living with PF.
Detailed description
Background: Pulmonary fibrosis is a progressive, irreversible fibrotic lung disease that requires long-term treatment. People with a diagnosis of pulmonary fibrosis are known to have reduced health-related quality of life, furthermore, it is common for such individuals to experience anxiety and depression. Therefore, interventions to support these individuals are essential to improve their psychological health. Mindfulness is increasing in popularity but retention in these programmes can be challenging. Condensed programmes have great potential but require statistical and individual evaluation. The Compassionate Mindful Resilience Program is a 4-week course that teaches simple, effective, evidence-based practices, skills and techniques. Methods: This study aims to establish the feasibility of a randomised controlled trial to evaluate the effectiveness of the Compassionate Mindful Resilience Program in improving the psychosocial well-being of people with a diagnosis of pulmonary fibrosis. The trial will be conducted to test procedures, outcomes and validated tools; estimate recruitment and attrition rates; and calculate the sample size required for a future definitive multi-centre randomised controlled trial. The study will also utilise qualitative methods to explore the acceptability of the intervention to the study population. In keeping with CONSORT guidelines. The SPIRIT guidelines and checklist will be utilised to report the study. Discussion: This study will implement a four-week mindfulness intervention and its utility for people with Pulmonary Fibrosis. The investigators aim to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by this condition. If the study demonstrates the practicability of delivering the online 4-week Compassionate Mindful Resilience program with adequate recruitment, the investigators will be able to determine the feasibility of progression to a randomised controlled clinical trial to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by Pulmonary Fibrosis.
Interventions
It is an internationally accredited 4-week programme with 2-hour online sessions delivered via Microsoft Teams
Sponsors
Study design
Eligibility
Inclusion criteria
* have a confirmed diagnosis of PF * be aged 18 years or older * reside in the UK or Ireland * have the capacity to provide informed consent * demonstrate a commitment to attend all four CMR sessions (demonstrated through discussion with the mindfulness teacher during screening) * have access to an internet-enabled device.
Exclusion criteria
* No diagnosis of PF * under 18 years old * live outside of UK or Ireland * no capacity to provide informed consent * not willing to attend all four CMR sessions * no access to an internet-enabled device.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of the intervention | From enrollment until the follow up interview was completed (up to 10 weeks) | Adherence |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The feasibility of collecting data on anxiety, depression, well-being, mindfulness, resilience, and self-compassion | Baseline (week 1), post-CMR (week 4), and four-week follow-up (week 8) | These were measured via online surveys at baseline, post-CMR, and four-week follow-up |
Countries
United Kingdom